Law360, New York (May 07, 2010, 6:09 PM ET) -- Watson Pharmaceuticals Inc. said Friday that it had reached a settlement with Teva Pharmaceutical Industries Ltd. in a patent infringement dispute over the oral contraceptive Seasonale.
Under the settlement agreement, Teva subsidiary Teva Women's Health Inc. will grant Watson subsidiary Watson Laboratories Inc. a fully paid-up license to the U.S. patents covering Seasonale tablets, and Watson will continue marketing its generic equivalent product known as Quasense, according to Watson.
Morristown, N.J.-based Watson admitted that the licensed patents were valid and enforceable, but the remaining terms of...
Watson Gets License From Teva As Part Of Settlement
To view the full article, take a free trial now.
